Williams Paul Anthony 4
4 · Emergent BioSolutions Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Emergent BioSolutions SVP Paul Williams Sells 8,655 Shares
What Happened
Williams Paul Anthony, SVP, Products Business at Emergent BioSolutions (EBS), had a disposition to the issuer on Feb 6, 2026: 8,655 shares were disposed at $10.92 per share for $94,513. In the same settlement, 1,022 shares were withheld to cover tax liabilities at the same $10.92 price for $11,160. These transactions relate to the settlement of performance-based equity (see footnotes); the transactions are sales/withholdings rather than open-market purchases.
Key Details
- Transaction date: February 6, 2026. Price: $10.92 per share.
- Disposition (D): 8,655 shares — $94,513. Tax withholding (F): 1,022 shares — $11,160.
- Shares owned after the reported transactions: not disclosed in the filing.
- Footnote F1: These were performance stock units (PSUs) under the company’s Stock Incentive Plan. The Compensation Committee certified 2023–2025 PSUs at a 25% payout, resulting in an actual award of 2,884 shares on Feb 6, 2026 (less than earlier estimates).
- Footnote F2 / code F: 1,022 shares were withheld to pay taxes associated with vesting/settlement of restricted awards.
- Filing: Report filed Feb 10, 2026; based on the Feb 6 transaction date this appears to be timely.
Context
The primary event was settlement of performance-based equity (PSUs) certified at a 25% payout of target. The disposition to the issuer and the shares withheld for taxes are administrative steps commonly used to net-settle awards and cover tax obligations — not an open-market sale. For retail investors, purchases typically carry more interpretive weight; this filing documents routine award settlement and tax withholding rather than a spontaneous insider buy.
Insider Transaction Report
- Disposition to Issuer
Common Stock
[F1]2026-02-06$10.92/sh−8,655$94,513→ 77,216 total - Tax Payment
Common Stock
[F2]2026-02-06$10.92/sh−1,022$11,160→ 76,194 total
Footnotes (2)
- [F1]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 2,884 shares of common stock, which is less than the 11,539 shares previously reported on March 02, 2023 and June 09, 2023.
- [F2]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units